Risk Management Expert, VP of Innovation@Caparna Inc
Verified
EXECUTIVE SUMMARY
Internationally recognized physician-executive and Chief Medical Officer with over 28 years of leadership across clinical research, pharmacovigilance, and global regulatory strategy. A strategic innovator with deep expertise in oncology, hematology, and immuno-oncology, guiding product development from IND through post-market across the US, EU, UK, LATAM, and APAC. Proven ability to shape clinical trial design, lead multidisciplinary teams, and scale enterprise-wide medical operations. Experienced board advisor and keynote speaker with strong networks in academic medicine, regulatory agencies, and pharma partnerships. Passionate about leveraging AI, real-world evidence, and data infrastructure to accelerate patient-centered outcomes and improve global health equity.
BOARD MEMBER PROFILE
Key Value Areas
- Clinical Relevance: Extensive background in global drug development, patient safety, and EHR optimization across high-impact therapeutic areas.
- Strategic Advisory: Advised multiple organizations on global launch readiness, regulatory filing strategy, and clinical trial governance.
- Network Development: Strong connections with CMIOs, KOLs, trial leaders, and innovation executives across oncology and academic medicine.
- Mission Advocacy: Frequent speaker at HLTH, DIA Europe, BIO-Europe, World Drug Safety EU, World Drug Safety Americas, and active contributor to innovation forums on AI in healthcare.
CORE COMPETENCIES
Clinical Trial Strategy & Oversight
Global Regulatory Affairs (FDA, EMA, MHRA, APAC, LATAM)
Pharmacovigilance & Risk Management
Health Data Infrastructure & AI Applications
Cross-Functional Team Leadership
Strategic Partnerships in Pharma/Academia
Medical Governance & Safety Science
Innovation Advocacy & Thought LeadershipMore...
Andrea Blank
Vice President@Orca Bio
Verified
Andrea is a seasoned healthcare executive with a unique blend of clinical and commercial expertise, specializing in oncology and cell therapy. With over 15 years of experience spanning clinical practice, medical affairs, and strategic leadership, she has played a pivotal role in the successful launch of transformative therapies, including Yescarta and Tecartus. Andrea holds an Oncology Nurse Practitioner degree and an MBA from Notre Dame, enabling her to bridge the gap between science and strategy.More...